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nanospheres for thermoresponsive controlled
release†
Simon J. Holder,*a Glen Woodward,a Beulah McKenzieab
and Nico A. J. M. SommerdijkbWe demonstrate the controlled release of pyrene, as a model hydro-
phobic molecule, from self-assembled bicontinuous nanospheres
formed from an amphiphilic block copolymer. The bicontinuous
polymer nanospheres act as efficient nanocarriers and the incorpo-
ration of hydrophobic poly(alkyl methacrylate) blocks introduces a
temperature responsive component to the hydrophobic core.Block copolymer self-assembled aggregates have long been
studied as nanocarriers for the controlled delivery of encapsu-
lated chemicals, with particular focus on the controlled delivery
of pharmaceuticals in biomedical applications. To date most
research has focussed on the use of spherical micelles and
vesicles (polymersomes) with some studies utilising cylindrical
micelles.1,2 We have recently demonstrated the existence of self-
assembled bicontinuous polymer nanospheres (BPNs) from
amphiphilic block copolymers with low weight fractions of
hydrophilic blocks (<25%).3–5 Whilst micelles and vesicles have
primarily been studied for the encapsulation and release of
lipophilic and hydrophilic compounds respectively, BPNs offer
the potential for dual release formulations (e.g. a lipophilic and
a hydrophilic pharmaceutical) stemming from the coexistence
of the hydrophilic and hydrophobic interior regions. Herein we
present the results from our studies into successfully encapsu-
lating a hydrophobic compound (pyrene) into such nano-
spheres, and the subsequent controlled release of pyrene as a
function of temperature.
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58temperature, have been proposed for a number of potential
applications. One of the most common being for controlled
release from discrete self-assembled aggregates such as
micelles and vesicles in biomedical and pharmaceutical uses.1,2
Most of these thermoresponsive systems have been based upon
poly(N-isopropylacrylamide) and poly(oligoethylene glycol)6 and
other hydrophilic polymers.7 Upon heating above a given
temperature (the lower critical solution temperature) such
materials become insoluble. A different approach to utilising
thermoresponsive polymers has been described using poly(tri-
methylene carbonate) wherein a melting transition for a
hydrophobic polymer results in a profound change in perme-
ability.8,9 Unfortunately polymers for which crystallinity is a
property of the main chain have limitations, particularly with
respect to manipulation of the melting temperature. A prom-
ising approach to the use of semi-crystalline polymers for
temperature responsive applications is the incorporation of the
crystalline segment as a component of the side-chain; i.e.
removed from the backbone.10 By changing the alkyl chain
length the melting temperature can be modulated.11 The poly-
(alkyl (meth)acrylates) are ideal candidates for this approach.12
In this study we demonstrate the potential of this alternative
whereby we use poly(octadecyl methacrylate) as semi-crystalline
polymer component in a block copolymer bicontinuous nano-
sphere and demonstrate the release of pyrene across a range of
temperatures from 10 to 40 C.
We prepared poly(ethylene oxide)-block-poly(octadecyl
methacrylate) (PEO-b-PODMA) bicontinuous nanospheres in
aqueous solution by the slow addition of deionised water to a
THF solution of a PEO45-b-PODMA20 copolymer (Mn ¼ 10 900,
Mw/Mn ¼ 1.26, by GPC) followed by dialysis against water at
10 C (ESI†).5 The resulting BPNs displayed a bicontinuous
internal structure of interpenetrating PODMA and PEO–water
domains with average pore diameters of 20 nm as characterised
by cryo-TEM and cryo-ET. The resulting size distribution was
monomodal with a z-average diameter of 180 3 nm, a number-
average diameter of 127 8 nm and polydispersity index of 0.27
by DLS and 235  16 nm by TEM (Fig. 1a, c and ESI†). BPNsThis journal is © The Royal Society of Chemistry 2014
Fig. 1 TEM micrographs of PEO-b-PODMA micelles (a) with no pyr-
ene (no staining), (b) with pyrene encapsulated (negative staining).
Cryo-TEM micrographs of bicontinuous nanospheres (c) without
pyrene and (d) with pyrene, illustrating internal morphology.
Fig. 2 Normalised fluorescence emission spectra of pyrene in water
(red line) and encapsulated in bicontinuous micelle (black line). The
inset shows the spectra prior to normalisation.
Communication RSC Advancesresemble cubosomes generated by molecular amphiphiles
which are usually stabilised by PEO based additives.13 Such
cubosomes have been proposed and studied for a number of
controlled delivery applications.14,15 Whilst our bicontinuous
polymeric nanospheres have lower degrees of order than those
of their molecular analogues they are easily prepared, their
components (PEO biocompatible corona and alkyl chain inte-
riors) are intrinsic to the structure and open to ready modi-
cation, and crucially they are kinetically stable. By following
identical preparation conditions but using a THF solution of
pyrene (Py) in place of pure THF we were able to form bicon-
tinuous nanospheres with encapsulated Py with a monomodal
distribution with a z-average diameter of 268  23 nm, a
number-average diameter of 141  37 nm, a polydispersity
index of 0.27 by DLS (number average) and an average diameter
of 222 86 nm by TEM (Fig. 1b, d and ESI†). Py was chosen as a
model for the controlled release of hydrophobic compounds
owing to its hydrophobic character with very low water solubility
(typically in the range 2  107 to 10  107 mol dm3).16,17
Since a dialysis (at 10 C) was involved in the preparation, it was
necessary to demonstrate that a signicant amount of Py was
still present and retained in the nanospheres. This was
demonstrated by analysis of the uorescent spectra of the Py
encapsulated PEO–PODMA solution with that of a Py solution
prepared in the absence of the copolymer (Fig. 2). Three aspects
of the emission spectra demonstrated encapsulation: (i) a
signicant difference in emission intensities for otherwise
identical quantities of Py, indicative of solubilised Py; (ii) the
comparison of the spectra gave I3 : I1 ratios (I1 is the 0–0 vibronic
band at 372 nm and I3 is the 0–737 band at 383 nm) of 1.03 for
the encapsulated Py and 0.67 for the Py in water, indicative of PyThis journal is © The Royal Society of Chemistry 2014in a relatively weakly polar environment for the micellar
dispersion, and a highly polar environment in water;5,18,19 (iii) a
strong excimer emission (lmax ¼ 471 nm) for the Py in the
micellar dispersion; indicative of localised high concentrations
of Py.
We previously reported that upon heating from 5 C to 45 C
a phase transition at 20–25 C was observed for the bicontin-
uous components of the PODMA regions of the block copoly-
mer.5 To study the release of Py into the aqueous environment
upon heating, samples of the Py–PEO–PODMA dispersion were
isolated from pure water (3 dm3) by a dialysis membrane and
kept at a set temperature (10, 20, 25, 30 and 40 C). The relative
quantity of Py released into the larger aqueous environment was
determined by recording uorescent spectra of samples at given
times over a 6 to 7 hour period (Fig. 3a). A calibration curve of Py
in water was used to determine Py concentration variance with
time (see ESI†). To conrm that the release of the Py was
occurring from the nanospheres the BPN solutions were also
analysed by uorescence spectroscopy aer dialysis. In all cases
a clear decrease in emission intensity was observed corre-
sponding to loss of pyrene from the nanospheres (Fig. 3b). The
release efficiencies were estimated from integration of the
curves relative to the undialysed pyrene containing BPN sample
(see ESI†). As can be seen (Fig. 3b) a relative maximum in
release efficiency (72% release of encapsulated pyrene) was
observed at 40 C. These results also allowed an estimate of the
loading capacity and gave a value of 43 mg pyrene per mg of BPN
(circa 4% loading). A full study of release efficiency involving
innite sink conditions is needed and is currently underway.
The release proles for 10 C, 20 C and 25 C are very
similar, but for 30–40 C there is an increasing rate of release of
Py (Fig. 3a). The plot of fractional release against time from 10
to 60% release (see ESI†) is linear indicating zero order kinetics
and Case-II transport properties (a non-Fickian diffusion
release mechanism predominates). Fractional release times
were based on extrapolation of the curves in Fig. 3a to constant
values resulting from saturation of the water solution by Py
which varies with temperature (see ESI†).16 The change in
release rates (taken from the slope of the linear ts, ESI†) showRSC Adv., 2014, 4, 26354–26358 | 26355
Fig. 3 Release of pyrene from bicontinuous nanospheres formed
from PEO45-b-PODMA20, (a) release profiles at various temperatures
and (b) photoluminescent spectra of Py nanosphere dispersions before
and after dialysis at stated temperatures.
Fig. 4 (a) Time taken for indicated percentage release of pyrene from
bicontinuous nanospheres at given temperatures. (b) Comparison of
fractional release profiles of ‘free’ pyrene (see text) and pyrene
encapsulated in bicontinuous nanospheres.
RSC Advances Communicationthe dramatic change from below 25 C to above 25 C (Fig. 4a),
with fractional release rate constants of 0.0030 s1 at 25 C and
0.0051 s1 at 30 C and 0.01003 s1 at 40 C. This demonstrates
the effect of the melting of the hydrophobic PODMA block on Py
release and the potential of poly(alkyl methacrylates) in ther-
moresponsive controlled delivery applications.
As has become increasingly apparent over the past few years,
dynamic equilibrium dialysis conditions are not always suitable
for reliably determining the release kinetics of lipophilic
compounds from solid nanoparticles and micelles.20–24 To a
large part the apparent release kinetics in such set-ups are a
result of the partition coefficient between particle and lipophilic
compound within the dialysis chamber, any binding to the
dialysis membrane (potentially complicated by nanoparticle
effects on the membrane itself) and diffusion rates across the
dialysis membrane any and all of which can be the limiting
factor in the rate of appearance of the lipophile in the receiving
chamber. This can complicate data interpretation and can lead
to incorrect conclusions about the release kinetics.25 As a
control experiment, an identical procedure was followed
whereby the release of Py from a dispersion prepared without
the PEO–PODMA present was monitored. Since Py is only26356 | RSC Adv., 2014, 4, 26354–26358sparingly water soluble the bulk of the Py remained undis-
solved. Transfer of the solid Py–water mixture to dialysis tubing
and monitoring of the release proles showed that release of Py
into surrounding water was signicantly faster than that of the
encapsulated Py at 40 C and at 10 C (Fig. 4b). However the
difference in release rates for ‘free’ and encapsulated pyrene
and change in rates with temperature for the encapsulated
pyrene indicate a controlled release mechanism.
Despite the reservations currently held about the full validity
of dynamic equilibrium dialysis in studying release mecha-
nisms, a number of drug dissolution models were tted to the
fractional release proles namely the Higuchi, zero order,
Weibull and Korsmeyer–Peppas (power law) models.26–31 Of
these the Korsmeyer–Peppas model most closely matched the
release proles (between 10 and 60% release) (see ESI†). This




where Mt/MN is the fraction released at time t, a is a constant
incorporating structural and geometrical characteristics of the
drug dosage form and n is the release exponent which is
indicative of the release mechanism. A release exponent (n) ofThis journal is © The Royal Society of Chemistry 2014
Communication RSC Advances0.43 for a spherical geometry indicates a release mechanism
following Fickian diffusion, 0.43 < n < 0.85 indicates an anom-
alous diffusion mechanism (where encapsulant release is
primarily determined by polymer relaxation rates) and n > 0.85
Case-II transport where release rate is determined predomi-
nantly by polymer relaxation processes in non-swellable and
non-degradable systems. By comparing the n across the
temperatures (see ESI†) it was observed that from 10–30 C the
exponent n took values >1.0 indicative of Super Case-II transport
occurring where polymer relaxation properties were the deter-
mining factor for the release rates over Fickian diffusion
determined by Py concentration gradients.32 This is in line with
transport mechanisms observed for non-swellable and non-
degradable synthetic polymers.32–34 The exact location of the Py
in the BPNs is uncertain. The uorescence data (Fig. 2)
demonstrates that the majority of the Py is not simply adsorbed
onto the surface of the spheres (a substantially lower I3/I1 ratio
would be expected as a consequence of the polarity of the
immediate environment).18 Thus there are four possible
internal regions in the BPNs that can be considered as sites for
the Py; (i) the PEO + H2O region, (ii) the PEO–PODMA interfacial
region, (iii) the PODMA amorphous polar backbone region, (iv)
the crystalline octadecyl region) (Scheme 1). The PEO–H2O
region can be discounted since the observed I3/I1 ratio is much
higher than would be expected and the octadecyl crystalline
region can be discounted due to the lower I3/I1 ratio than
expected (Fig. 2) and it is known that chromophores are
excluded from the crystalline regions in polymers.19 Thus the Py
can be postulated to reside predominantly in the PEO–PODMA
interfacial region and/or the PODMA backbone region. The
observed I3/I1 ratio precludes neither of these possibilities. That
the rate of release increases signicantly above Tm of PODMA is
in line with the previously observed dramatic increases in gas
permeability above Tm. The increase in permeability is directly
attributable to a decrease in backbone stiffness in wholly
amorphous state compared to the semi-crystalline state. Thus
for the BPNs we suggest that above Tm the relaxation rates of the
PODMA chains increase and diffusion through the polymer is
greatly enhanced.
In summary we have demonstrated that self-assembled
bicontinuous nanospheres formed from amphiphilic block
copolymers can be used to encapsulate and therefore transport
hydrophobic compounds in water. They have been demon-
strated to display controlled release and furthermore the releaseScheme 1 Illustration of potential regions for pyrene inclusion in BPN.
This journal is © The Royal Society of Chemistry 2014rate can be signicantly increased through an increase in
temperature.
Finally we note that the melting temperatures of the poly-
(alkyl(meth)acrylates) are readily altered through the use of
different lengths of alkyl chains as substituents and our current
work is investigating raising the transition temperatures to
greater than 30 C.
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